Office of Research & Development |
|
Project Number: IK2BX002440-01
Title: Development of the potent anti-malarial and anti-Toxoplasma drug, ELQ-316
Principal Investigator: Joseph ("Stone") Doggett
FY 2017 Funding Amount: $249,399
Location: Portland, OR Research Service: Biomedical Laboratory R&D Project Period: January 2014 - December 2018 |
Abstract: View abstract and other project information on NIH RePORTER Go To NIH RePORTER ⇑ |